Clinical Trials – Page 17

Allogene Halts Leukemia CAR-T Trial Enrollment Due to Breyanzi Competition

8 months ago talkbio0Tagged Allogene, Breyanzi, CAR-T, cema-cel, Clinical Trials, leukemia, Myers, squibb

Allogene, CAR-T therapy, leukemia, Breyanzi, Bristol Myers Squibb, cema-cel, clinical trials

FDA Issues Second Clinical Hold on Kezar’s Zetomipzomib Program Within Two Months

8 months ago talkbio0Tagged Autoimmune Chronic Hepatitis, Clinical Trials, Kezar Life Sciences, Lupus Nephritis, Study on Hold, United States Food and Drug Administration, Zetomipzomib

Kezar Life Sciences, Zetomipzomib, FDA Clinical Hold, Lupus Nephritis, Autoimmune Hepatitis, Clinical Trials

Neurogene’s Rett Syndrome Gene Therapy Shows Efficacy but Raises Safety Concerns

8 months ago talkbio0Tagged AAVS1 gene, Clinical Trials, concerns, Effectiveness, gene therapy, Neurogene, NGN-401, Rett Syndrome, Safety, vector

Neurogene, Rett syndrome, gene therapy, NGN-401, AAV vector, clinical trial, safety concerns, efficacy results

Tezspire Shows Promise in Treating Chronic Rhinosinusitis with Nasal Polyps

8 months ago talkbio0Tagged amgen, AstraZeneca, Chronic sinusitis, Clinical Trials, CRSwNP, Inhibitor, Nasal congestion (finding), Nasal Polyps, Tezspire, TSLP gene

Tezspire, chronic rhinosinusitis with nasal polyps (CRSwNP), AstraZeneca, Amgen, WAYPOINT trial, TSLP inhibitor, nasal congestion, nasal polyps.

Sarepta Discontinues Development of SRP-5051 for Duchenne Muscular Dystrophy Due to Safety Concerns

8 months ago talkbio0Tagged Clinical Trials, concerns, Hypomagnesemia, Muscular Dystrophy, Duchenne, Safety, SRP-5051, United States Food and Drug Administration

Sarepta Therapeutics, SRP-5051, Duchenne muscular dystrophy, DMD, safety concerns, hypomagnesemia, FDA, clinical trials

Advancements in Bispecific Antibody Therapies: Recent Deals and Clinical Data on VEGF-Targeting Agents

8 months ago talkbio0Tagged Age related macular degeneration, Agreement, Antibodies, Bispecific, Cancer Therapeutic Procedure, Clinical Trials, Exudative age-related macular degeneration, Neovascular, Royalty, Vascular Endothelial Growth Factor A

Bispecific antibodies, VEGF, neovascular age-related macular degeneration (nAMD), cancer therapy, clinical trials, royalty agreements.

Arcus Biosciences Reveals Positive Data from Terminated TIGIT Combo Trial, Supporting Future Development

8 months ago talkbio0Tagged Arcus, Cancer Therapeutic Procedure, Clinical Trials, Combo, domvanalimab, TIGIT gene, zimberelimab

Arcus Biosciences, TIGIT combo, domvanalimab, zimberelimab, cancer treatment, clinical trials

Gilead Exceeds COVID-19 Drug Sales Projections, Faces $1.75 Billion Loss on Trodelvy Trial Failure

8 months ago talkbio0Tagged Clinical Trials, COVID19 (disease), drug sales, Failure (biologic function), Gilead, Trodelvy, Veklury

Gilead, COVID-19, Veklury, Trodelvy, drug sales, clinical trial failure

Medidata Introduces Bundled Solutions for Oncology and Vaccine Trials to Enhance Study Efficiency

8 months ago talkbio0Tagged adaptive trial designs, Bundled, Clinical Trials, Diversity, Efficiency, Endpoints, Medidata, Patient-Centered, Solutions, trials, Vaccines

Medidata, Oncology Trials, Vaccine Trials, Bundled Solutions, Clinical Trial Efficiency, Patient-Centered Endpoints, Adaptive Trial Designs, Trial Diversity

Gilead and Arcellx Highlight Promising CAR T Therapy for Multiple Myeloma with Enhanced Safety Profile

8 months ago talkbio0Tagged Arcellx, Automobiles, Clinical Trials, Effectiveness, Gilead, Multiple Myeloma, safety profile, T therapy

CAR T therapy, multiple myeloma, anito-cel, Gilead, Arcellx, safety profile, efficacy, clinical trials